What is Bowhead's latest dividend and current dividend yield?

Did Bowhead beat or miss consensus estimates last quarter?

What guidance did Bowhead's management provide for the next earnings period?

What is the revenue and EPS growth rate for Bowhead year over year?

What is Bowhead's gross profit margin?

What were the key takeaways from Bowhead’s earnings call?

What does Bowhead do and what are its main business segments?

What is the market's earnings forecast for Bowhead next quarter?

- **Record Growth**: Q3 GWP up 17.5% to $232M, driven by 20% Casualty and 83% Baleen premium growth. Adjusted EPS of $0.47 reflects 25.5% net income increase.
- **Operational Efficiency**: Expense ratio drops to 29.5% via automation, with plans for further reductions through tech scaling.
- **Investment Strength**: 31% YoY investment income growth to $15M, supporting 16% equity increase to $431M.
- **Strategic Focus**: Expanding into cyber liability and healthcare exclusions, avoiding competitive D&O and financial institution markets.

**【CEO Summary Section】**
- Q3 2025 gross written premiums (GWP) increased 17.5% YoY to $232 million, driven by 20% growth in Casualty and 11% in Healthcare Liability. Adjusted net income rose 25.5% to $15.8 million, with EPS of $0.47.
- Casualty division focuses on excess liability for construction, distribution, and public entities, avoiding high-risk classes. Healthcare division benefits from exclusions for sexual abuse claims.
- Baleen, the digital underwriting platform, generated $6.2 million in Q3, 83% growth from Q2, targeting small to mid-market cyber liability.
- Expense ratio improved to 29.5% (down 40bps YoY) due to automation and workflow optimization.

**【COO Operational Efficiency】**
- Technology initiatives streamlined underwriting, claims processing, and actuarial modeling, reducing manual tasks and enhancing scalability.
- Targeting further expense ratio reductions through operational leverage and technology-driven growth.

**【CFO Financial Highlights】**
- Net investment income grew 31% YoY to $15 million, with a book yield of 4.8% and AA credit quality. Total equity reached $431 million, up 16% YoY.
- Combined ratio improved to 95.4%, with a 1.4pt increase in loss ratio due to casualty mix shift. Fee increases with American Family offset by expense management.
- Planning to access non-equity capital by end-2025 to support growth without equity dilution.

**【Q&A Highlights】**
- Cyber and D&O markets remain competitive, with limited pricing power. Construction project growth expected post-government shutdown, but lumpy and selective.
- Sexual abuse exclusions gaining traction in healthcare, creating new market opportunities. No immediate plans for new product lines beyond existing tech-driven expansion.
- 2026 capital strategy excludes equity raises; exploring debt and reinsurance options. Reserves remain conservative with 88% IBNR reliance on industry data.

Bowhead Specialty Holdings Inc. (BOW) Q3 2025 Earnings Call Transcript

- **Record Growth**: Q2 GWP up 32% to $232 million, driven by Casualty and Healthcare divisions.
- **Profitability**: Adjusted ROAE of 12.8%, with improving expense ratio to 30.6%.
- **Strategic Initiatives**: Baleen flow underwriting shows promise, targeting sub-30% expense ratio.
- **Market Trends**: Casualty discipline persists; D&O stabilization offers opportunities, while cyber remains competitive.
- **Investment Strength**: 56% growth in investment income, with cautious optimism on yield expansion.

**【CEO Summary Section】**
- **Q2 2025 Results**: Gross written premiums (GWP) increased 32% to $232 million, adjusted net income rose 62% to $12.8 million, and diluted adjusted EPS grew 32%.
- **Divisional Growth**: Casualty division led with 32% GWP growth to $151 million, driven by excess Casualty. Professional Liability grew 23% to $55 million, and Healthcare Liability expanded 39% to $24 million.
- **Market Insights**: Casualty market remains disciplined; construction project growth is slowing due to tariffs and labor shortages. Public D&O shows stabilization, while cyber liability remains competitive.

**【CFO Financial Commentary】**
- **Financial Performance**: Adjusted return on average equity (ROAE) was 12.8%. Loss ratio was 66.2% (up 0.7% YoY due to Casualty mix and seasonality), expense ratio improved to 30.6% (down 3.2% YoY).
- **Investment Portfolio**: Net investment income rose 56% to $13.7 million, with a book yield of 4.7% and new money yield of 4.8%. Total equity reached $408 million, with diluted book value per share at $12.04 (9% YoY increase).
- **Reserve Updates**: 87.5% of reserves are industry-based (IBNR). Q4 annual reserve review will incorporate updated industry data.

**【Q&A Key Highlights】**
- **Market Fungibility**: Financial institutions capacity remains segment-specific, not leaking into other lines.
- **Social Inflation**: Casualty claims rising due to layering and carrier settlements; less impact on professional liability.
- **Investment Outlook**: Portfolio growth driven by long-tail premiums; cautious on interest rate risk, targeting 4.8% new money yield.
- **Baleen Update**: Flow underwriting platform shows steady growth, with technology enabling scale.
- **Expense Ratio**: Targeting below 30% but facing headwinds from increased American Family fees.
- **Growth Drivers**: Casualty for absolute growth, Baleen for percentage growth.
- **Reserve Assumptions**: Q4 review will adjust loss picks based on industry trends.
- **Investment Strategy**: Focus on spread sectors; no exotic instruments to chase yield.

Bowhead Specialty (BOW)-5 Aug 25-2025 Q2 Earnings call transcript

- **26% Premium Surge**: Q1 2025 premium up to $175M, led by 34% Casualty growth and Baleen's 131% QoQ expansion. 
- **Profitable Growth**: 66.9% loss ratio reflects disciplined underwriting; 30.4% expense ratio shows cost control. 
- **Baleen Breakthrough**: $2.7M in 3Q, targeting 20%+ annual growth via tech-enabled small market underwriting. 
- **Investment Yield**: 4.7% portfolio return drives $12.6M net income, +64% YoY. 
- **Cross-Cycle Resilience**: $95B E&S market addressable; 20%+ annual premium growth target reaffirmed.

**【CEO Summary Section】**
- Q1 2025 premium growth of 26% to $175 million, driven by Casualty (+34%), Healthcare Liability (+10%), and Baleen ($2.7M, +131% QoQ). 
- Casualty excess book growth reflects disciplined underwriting with double-digit rate increases and lower limits. 
- Baleen expands distribution network, targeting 20%+ annual growth with small/middle market focus. 
- Cross-cycle strategy emphasizes profitable growth in E&S market, with $95B addressable opportunity.

**【CFO Financial Commentary】**
- Adjusted net income: $11.5M ($0.34 EPS), vs. $9.2M ($0.27 EPS) prior year. 
- Loss ratio: 66.9% (vs. 64.4% FY24), driven by prior year reserve adjustments and ULAE timing. 
- Expense ratio: 30.4% (vs. 31.4% FY24), benefiting from scale and investment income growth (+64% YoY to $12.6M). 
- Book value: $11.61/share (+5% QoQ), supported by 4.7% portfolio yield and 2.8-year duration.

**【Q&A Key Themes】**
- **Competitive Environment**: Casualty excess market remains disciplined, while Professional Liability sees stabilization. No direct impact from California wildfires. 
- **Reserve Mechanics**: Prior year reserve adjustments (+0.4pts) and ULAE timing (+2.1pts) explain loss ratio increase; normalized by year-end. 
- **Baleen Growth**: Broker adoption uneven, but 2H25 ramp-up expected; 20%+ annual premium growth target maintained. 
- **Tax Rate**: Q1 21% rate driven by stock comp benefits; FY25 rate ~24% expected. 
- **Technology Investment**: Balancing expense efficiency with underwriting tools like Baleen for small/middle market underwriting.

Bowhead Specialty (BOW)-6 May 25-2025 Q1 Earnings call transcript

- **Record Growth**: 37% premium growth in 2024, driven by 56% expansion in excess casualty and disciplined underwriting.
- **Strategic Wins**: Baylin Specialty generated $1.2M in Q4, with 2025 momentum expected. Environmental liability product launched in Q4.
- **Financial Strength**: 15.3% ROE, 31.4% expense ratio, and $12M investment income highlight strong capital management.
- **2025 Outlook**: 20% premium growth target, mid-90s combined ratio, and mid-teens ROE supported by scalable platforms and underwriting discipline.
- **Risk Management**: No property exposure, limited auto fleet, and conservative reserve practices mitigate long-tail risks.

**【CEO Summary Section】**
- **2024 Performance Highlights**: Achieved 37% premium growth ($696M total), with 76% written on E&S basis. Casualty division grew 56% through rate increases and selective underwriting. Maintained underwriting-first culture, avoiding property and auto risks.
- **Strategic Expansions**: Launched Baylin Specialty (low-touch flow underwriting) in Q2, generating $1.2M in Q4. Introduced first environmental liability product in Q4.
- **2025 Outlook**: Target 20% premium growth, driven by casualty and Baylin momentum. Focus on disciplined underwriting, expense control, and cross-cycle profitability.

**【CFO Financial Commentary】**
- **Q4 Financials**: Adjusted net income $14.1M (143% YoY), ROE 15.3%. GWP up 26% to $185M, with Casualty (+43%) and Professional Liability (+7%) leading growth.
- **Loss Ratio**: Full-year 64.4% (vs. 63.0% in 2023), driven by casualty mix and industry benchmark adjustments. No prior-year reserve development.
- **Expense Ratio**: 31.4% (down 0.5pts YoY), benefiting from scale and cost management. Investment income up 80% to $12M, with 4.6% book yield.
- **2025 Guidance**: Combined ratio mid-90s, ROE mid-teens. Expense ratio ~30%, with fronting fee increase offset by scaling.

**【Q&A Key Highlights】**
- **Loss Ratio Trends**: Q4 loss ratio volatility due to annual actuarial review and mix changes. 2025 loss ratio expected to rise as older, lower-loss years roll off.
- **Underwriting Talent**: Competing for scarce excess casualty talent, but scalable Baylin platform reduces reliance on traditional underwriters.
- **Line Growth**: Casualty excess rates sustainable due to social inflation and verdict trends. Health care liability growth expected in hospital and managed care E&O.
- **Expense Management**: Fronting fee increase (2.75% in Q2) and bonus payouts may pressure Q1 expenses, but long-term leverage from premium growth expected.


BOW

BOW fundamentals

Earnings Call

You can ask Aime